PTPRC and periodontal disorder: The cancer group had the highest number of immune cells (CD45+) in saliva (99,240 ± 38,789) and was significantly higher than control patients (7,945 ± 5,790, P < 0.038) but not periodontal disease patients (83,180 ± 21,160).